Vaccines and Preventable Diseases:
Combined Tdap Vaccine
Combined Tetanus, Diphtheria and Pertussis (Tdap) Vaccines
Adolescent and Adult Recommendations:
On June 30, 2005 the Advisory Committee on Immunization Practices (ACIP) voted to recommend the routine use of Tdap vaccines in adolescents aged 11–18 years in place of tetanus and diphtheria toxoids (Td) vaccines.
On October 26, 2005 the ACIP voted to recommend routine use of a single dose of Tdap for adults 19-64 years of age to replace the next booster dose of tetanus and diphtheria toxoids vaccine (Td). The ACIP also recommended Tdap for adults who have close contact with infants <12 months of age.
On December 15, 2006 the MMWR published the ACIP recommendations.
- December 2006 MMWR: Preventing Tetanus, Diphtheria, and Pertussis Among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine
- February 2006 MMWR: Preventing Tdap Among Adolescents: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines
- Tetanus disease and vaccine information
- Diphtheria disease and vaccine information
- Pertussis disease and vaccine information
Note: On page 32 of CDC's Parents' Guide to Childhood Immunizations, it states that Tdap is recommended for children 7 years of age and older. This is incorrect. BOOSTRIX® is licensed for 10-18 year olds and ADACEL® is licensed for 11-64 year olds. Td should be used for children 7-9 years of age.
Pregnancy-related Recommendations:
May 30, 2008 MMWR: Prevention of Pertussis, Tetanus, and Diphtheria Among Pregnant and Postpartum Women and their Infants (ACIP Recommendations)
Content last reviewed on July 2, 2008
Content Source: National Center for Immunization and Respiratory Diseases